Sodium Hyaluronate



Indications and Reactions:

Role Indications Reactions
Primary
Arthralgia 33.3%
Osteoarthritis 33.3%
Patellofemoral Pain Syndrome 33.3%
Arthritis Bacterial 33.3%
Joint Swelling 33.3%
Pain In Extremity 33.3%
Secondary
Ill-defined Disorder 43.4%
Cataract Operation 12.0%
Blood Pressure Increased 9.6%
Product Used For Unknown Indication 8.4%
Osteoarthritis 6.0%
Cycloplegia 3.0%
Postoperative Care 2.4%
Keratitis 1.8%
Medication Dilution 1.8%
Mydriasis 1.8%
Analgesic Therapy 1.2%
Constipation 1.2%
Eye Irrigation 1.2%
Hypertension 1.2%
Infection 1.2%
Pyrexia 1.2%
Age-related Macular Degeneration 0.6%
Anaesthesia 0.6%
Immunosuppression 0.6%
Preoperative Care 0.6%
Keratopathy 24.1%
Injection Site Joint Pain 13.8%
Nausea 13.8%
Visual Acuity Reduced 10.3%
Drug Rash With Eosinophilia And Systemic Symptoms 6.9%
Anaphylactic Shock 3.4%
Conjunctival Bleb 3.4%
Keratitis Herpetic 3.4%
Prothrombin Time Shortened 3.4%
Retinal Injury 3.4%
Retinogram Abnormal 3.4%
Shock 3.4%
Spinal Compression Fracture 3.4%
Toxic Anterior Segment Syndrome 3.4%
Concomitant
Rheumatoid Arthritis 36.5%
Prophylaxis 8.0%
Hypertension 5.6%
Spinal Osteoarthritis 5.1%
Lumbar Spinal Stenosis 4.3%
Drug Use For Unknown Indication 4.0%
Constipation 3.8%
Product Used For Unknown Indication 3.8%
Gastritis 3.3%
Insomnia 3.2%
Periarthritis 3.0%
Dry Eye 2.9%
Gastritis Prophylaxis 2.9%
Osteoporosis 2.4%
Pain 2.4%
Osteoarthritis 2.1%
Prostate Cancer 2.0%
Chronic Obstructive Pulmonary Disease 1.7%
Dysthymic Disorder 1.7%
Asthma 1.6%
Pneumocystis Jiroveci Pneumonia 13.2%
Vascular Graft 8.5%
Gastroenteritis 7.5%
Speech Disorder 7.5%
Pneumonia 6.6%
Breast Cancer 5.7%
Nasal Sinus Cancer 5.7%
Intervertebral Discitis 4.7%
Pneumonia Aspiration 4.7%
Visual Impairment 4.7%
Headache 3.8%
Liver Disorder 3.8%
Spinal Compression Fracture 3.8%
Drug Ineffective 2.8%
Haemoptysis 2.8%
Intervertebral Disc Protrusion 2.8%
Miosis 2.8%
Mobility Decreased 2.8%
Pharyngoesophageal Diverticulum 2.8%
Somnolence 2.8%